Burning Rock Biotech Limited (BNR) Misses Q3 EPS by 39c

Burning Rock Biotech Limited (NASDAQ: BNR) reported Q3 EPS of (RMB1.71), RMB0.39 worse than the analyst estimate of (RMB1.32). Revenue for the quarter came in at RMB127.6 million versus the consensus estimate of RMB198 million.

For earnings history and earnings-related data on Burning Rock Biotech Limited (BNR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79